Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Megraud

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Gastroenterology|January 4, 2024
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022Yi-Chu Chen, Peter Malfertheiner, Hao-Ting Yu, et al.
Lancet Regional Health. Americas|December 9, 2025
Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line <i>Helicobacter pylori</i> eradication: a double-blind randomized controlled trialPatricio Andrés Medel-Jara, Gonzalo Latorre, Eduardo Fuentes-Lopez, et al.
United European Gastroenterology Journal|November 12, 2020
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practiceOlga P Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2026
Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World PracticeDuc Trong Quach, Jyh-Ming Liou, Javier P Gisbert, et al.
Gut|October 2, 2020
Screening and eradication of <i>Helicobacter pylori</i> for gastric cancer prevention: the Taipei global consensusJyh-Ming Liou, Peter Malfertheiner, Yi-Chia Lee, et al.
The New England Journal of Medicine|March 11, 2026
<i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group ReportJin Young Park, Yi-Chia Lee, Paul Moayyedi, et al.
Helicobacter|July 14, 2020
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)Olga P Nyssen, Angeles Perez-Aisa, Luis Rodrigo, et al.
The American Journal of Gastroenterology|November 20, 2023
Effectiveness of Helicobacter pylori Treatments According to Antibiotic ResistanceLuis Bujanda, Olga P Nyssen, June Ramos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 13, 2019
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of PatientsAdrian G McNicholl, Dmitry S Bordin, Alfredo Lucendo, et al.
Gut|September 22, 2020
European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patientsOlga P Nyssen, Dmitry Bordin, Bojan Tepes, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Gastroenterology|January 4, 2024
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022Yi-Chu Chen, Peter Malfertheiner, Hao-Ting Yu, et al.
Lancet Regional Health. Americas|December 9, 2025
Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line <i>Helicobacter pylori</i> eradication: a double-blind randomized controlled trialPatricio Andrés Medel-Jara, Gonzalo Latorre, Eduardo Fuentes-Lopez, et al.
United European Gastroenterology Journal|November 12, 2020
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practiceOlga P Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2026
Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World PracticeDuc Trong Quach, Jyh-Ming Liou, Javier P Gisbert, et al.
Gut|October 2, 2020
Screening and eradication of <i>Helicobacter pylori</i> for gastric cancer prevention: the Taipei global consensusJyh-Ming Liou, Peter Malfertheiner, Yi-Chia Lee, et al.
The New England Journal of Medicine|March 11, 2026
<i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group ReportJin Young Park, Yi-Chia Lee, Paul Moayyedi, et al.
Helicobacter|July 14, 2020
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)Olga P Nyssen, Angeles Perez-Aisa, Luis Rodrigo, et al.
The American Journal of Gastroenterology|November 20, 2023
Effectiveness of Helicobacter pylori Treatments According to Antibiotic ResistanceLuis Bujanda, Olga P Nyssen, June Ramos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 13, 2019
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of PatientsAdrian G McNicholl, Dmitry S Bordin, Alfredo Lucendo, et al.
Gut|September 22, 2020
European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patientsOlga P Nyssen, Dmitry Bordin, Bojan Tepes, et al.
Pageof 8